nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case
|
Gao, Guosheng |
|
|
49 |
1 |
p. 57-61 |
artikel |
2 |
A case report of cutaneous leishmaniasis: a misleading clinical presentation
|
Vanlier, Corentine |
|
|
49 |
1 |
p. 177-180 |
artikel |
3 |
Adenovirus diseases: a systematic review and meta-analysis of 228 case reports
|
Gu, Jie |
|
|
49 |
1 |
p. 1-13 |
artikel |
4 |
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
|
Peterhoff, David |
|
|
49 |
1 |
p. 75-82 |
artikel |
5 |
An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA
|
Laferl, H. |
|
|
49 |
1 |
p. 95-101 |
artikel |
6 |
Aspergillus fumigatus cholangitis in a patient with cholangiocarcinoma: case report and review of the literature
|
Rothe, Kathrin |
|
|
49 |
1 |
p. 159-164 |
artikel |
7 |
Cardiac manifestations of COVID-19 infection: the role of echocardiography in patient management
|
Dandel, Michael |
|
|
49 |
1 |
p. 187-189 |
artikel |
8 |
Cats and kids: how a feline disease may help us unravel COVID-19 associated paediatric hyperinflammatory syndrome
|
Alberer, Martin |
|
|
49 |
1 |
p. 191-193 |
artikel |
9 |
Comparison of four commercial SARS-CoV-2 IgG immuno-assays in RT-PCR negative patients with suspect CT findings
|
Van Praet, Jens T. |
|
|
49 |
1 |
p. 145-148 |
artikel |
10 |
Correction to: 2019 Novel coronavirus: where we are and what we know
|
Cheng, Zhangkai J. |
|
|
49 |
1 |
p. 197 |
artikel |
11 |
Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four cases
|
Hitzenbichler, Florian |
|
|
49 |
1 |
p. 181-186 |
artikel |
12 |
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs
|
Traugott, Marianna Theresia |
|
|
49 |
1 |
p. 171-175 |
artikel |
13 |
Different types of bullae of limbs with necrotizing fasciitis predict different outcome: a prospective study
|
Huang, Tsung-Yu |
|
|
49 |
1 |
p. 135-144 |
artikel |
14 |
First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”
|
Jakob, Carolin E. M. |
|
|
49 |
1 |
p. 63-73 |
artikel |
15 |
Gender differences and influenza-associated mortality in hospitalized influenza A patients during the 2018/19 season
|
Karolyi, Mario |
|
|
49 |
1 |
p. 103-110 |
artikel |
16 |
Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg
|
Hasanoglu, Imran |
|
|
49 |
1 |
p. 117-126 |
artikel |
17 |
Influenza-associated in-hospital mortality during the 2017/2018 influenza season: a retrospective multicentre cohort study in central Germany
|
Rößler, Steve |
|
|
49 |
1 |
p. 149-152 |
artikel |
18 |
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada
|
Hoffmann, Christian |
|
|
49 |
1 |
p. 111-116 |
artikel |
19 |
Pulmonary function in patients surviving to COVID-19 pneumonia
|
Fumagalli, Alessia |
|
|
49 |
1 |
p. 153-157 |
artikel |
20 |
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab
|
Comel, Andrea Claudio |
|
|
49 |
1 |
p. 195-196 |
artikel |
21 |
Risk factors for Covid-19 severity and fatality: a structured literature review
|
Wolff, Dominik |
|
|
49 |
1 |
p. 15-28 |
artikel |
22 |
Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?
|
Dalhoff, Axel |
|
|
49 |
1 |
p. 29-56 |
artikel |
23 |
Serum citrullinated histone H3 concentrations differentiate patients with septic verses non-septic shock and correlate with disease severity
|
Tian, Yuzi |
|
|
49 |
1 |
p. 83-93 |
artikel |
24 |
Survival case of rhinocerebral and pulmonary mucormycosis due to Cunninghamella bertholletiae during chemotherapy for acute myeloid leukemia: a case report
|
Yamamoto, Kei |
|
|
49 |
1 |
p. 165-170 |
artikel |
25 |
Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infection
|
Coste, Anne |
|
|
49 |
1 |
p. 127-133 |
artikel |